Kathryn Banfill
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kathryn Banfill has a total of 352 co-authors. Here are the top co-authors by number of shared publications:
- Corinne Faivre-Finn
University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK
16 shared publications - Marcel van Herk
Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
9 shared publications - Alan McWilliam
Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom
5 shared publications - Azadeh Abravan
Division of Cancer Sciences, The University of Manchester, Manchester, UNITED KINGDOM
5 shared publications - Fei Sun
Leeds Canc Ctr, Clin Oncol, Leeds, W Yorkshire, England
5 shared publications A. Abravan
4 shared publications
Latest Publications
- Open Access
- 17 September 2026
- Published by Elsevier in Clinical Oncology
- Vol. 60
Drivers of Change in Radiotherapy Practice: Lessons From a UK Tertiary Cancer Centre (2013–2023)
- 17 September 2026
- Published by Elsevier in Clinical Oncology
- Vol. 60
Open AccessDrivers of Change in Radiotherapy Practice: Lessons From a UK Tertiary Cancer Centre (2013–2023)
- 19 December 2025
- Published by Elsevier in Clinical Oncology
- Vol. 50, 104004
Royal College of Radiologists Guidance Statements on the Use of Auto-contouring in Radiotherapy
- 19 December 2025
- Published by Elsevier in Clinical Oncology
- Vol. 50, 104004
Royal College of Radiologists Guidance Statements on the Use of Auto-contouring in Radiotherapy
- Open Access
- 2 December 2025
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 36
Individualised dose mapping uncertainty estimation in the reirradiation setting
- 2 December 2025
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 36
Open AccessIndividualised dose mapping uncertainty estimation in the reirradiation setting
- Open Access
- 27 September 2025
- Published by Elsevier in Future Healthcare Journal
- Vol. 12 (4) , 100474
Fast-tracked and optimised: The impact of a one-stop lung cancer clinic on patient outcomes
- 27 September 2025
- Published by Elsevier in Future Healthcare Journal
- Vol. 12 (4) , 100474
Open AccessFast-tracked and optimised: The impact of a one-stop lung cancer clinic on patient outcomes
- Open Access
- 8 August 2025
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 35, 100333
Integrating Electronic Patient-Reported Outcome Measures (ePROMs) into Personalised Follow-up for Patients after Radiotherapy. A Feasibility Study
- 8 August 2025
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 35, 100333
Open AccessIntegrating Electronic Patient-Reported Outcome Measures (ePROMs) into Personalised Follow-up for Patients after Radiotherapy. A Feasibility Study
- Open Access
Feasibility, acceptability and clinical outcomes of a real-world, regional lung cancer prehabilitation programme for patients undergoing curative intent radiotherapy
Introduction Prehabilitation improves both physiological measurements and clinical outcomes for patients undergoing surgery for lung cancer. The feasibility, acceptability and efficacy of prehabilitation for patients having curative-intent radiotherapy for lung cancer is uncertain. Methods Prehab4Cancer (P4C) is a regional, community-based prehabilitation service for patients with cancer in Greater Manchester in the United Kingdom. We present an evaluation of the P4C service for patients undergoing curative-intent radiotherapy for lung cancer over a 2-year period. Feasibility was evaluated against prespecified key performance indicators. Objective physiological and subjective functional assessments were recorded before and after completion. Effects on mortality in comparison to a non-prehab cohort were assessed in an exploratory regression analysis. Results A total of 381 patients were referred to P4C via a web-based portal. 86% (329/381) were contacted by phone and 73% (279/381) completed an initial assessment. 45% (172/381) completed the prehab programme with a median of 7 (IQR 3-11) sessions during a median time to commencing treatment of 23 days (IQR 16 – 34). Median time from referral to assessment was 4 days (IQR 3 – 6) and 86% (239/279) were completed within 7 days of referral. Six-minute Walk Tests improved by an average of 30m (95% CI 20.6–41m, p=Conclusions The P4C programme has demonstrated feasibility, acceptability and effectiveness in patients with lung cancer undergoing curative-intent radiotherapy.
Open AccessFeasibility, acceptability and clinical outcomes of a real-world, regional lung cancer prehabilitation programme for patients undergoing curative intent radiotherapy
Introduction Prehabilitation improves both physiological measurements and clinical outcomes for patients undergoing surgery for lung cancer. The feasibility, acceptability and efficacy of prehabilitation for patients having curative-intent radiotherapy for lung cancer is uncertain. Methods Prehab4Cancer (P4C) is a regional, community-based prehabilitation service for patients with cancer in Greater Manchester in the United Kingdom. We present an evaluation of the P4C service for patients undergoing curative-intent radiotherapy for lung cancer over a 2-year period. Feasibility was evaluated against prespecified key performance indicators. Objective physiological and subjective functional assessments were recorded before and after completion. Effects on mortality in comparison to a non-prehab cohort were assessed in an exploratory regression analysis. Results A total of 381 patients were referred to P4C via a web-based portal. 86% (329/381) were contacted by phone and 73% (279/381) completed an initial assessment. 45% (172/381) completed the prehab programme with a median of 7 (IQR 3-11) sessions during a median time to commencing treatment of 23 days (IQR 16 – 34). Median time from referral to assessment was 4 days (IQR 3 – 6) and 86% (239/279) were completed within 7 days of referral. Six-minute Walk Tests improved by an average of 30m (95% CI 20.6–41m, p=Conclusions The P4C programme has demonstrated feasibility, acceptability and effectiveness in patients with lung cancer undergoing curative-intent radiotherapy.
- Open Access
- 18 November 2024
- Published by Elsevier in ESMO Real World Data and Digital Oncology
- Vol. 6
Challenges and opportunities for real-world evidence in clinical oncology—a view from the UK: proceedings of a national workshop
- 18 November 2024
- Published by Elsevier in ESMO Real World Data and Digital Oncology
- Vol. 6
Open AccessChallenges and opportunities for real-world evidence in clinical oncology—a view from the UK: proceedings of a national workshop
- Open Access
- 18 October 2024
- Published by Elsevier in JTO Clinical and Research Reports
- Vol. 5 (12) , 100742
Brief Report of a New Anatomical Region at Risk in Thoracic Radiotherapy: From Discovery to Implementation
- 18 October 2024
- Published by Elsevier in JTO Clinical and Research Reports
- Vol. 5 (12) , 100742
Open AccessBrief Report of a New Anatomical Region at Risk in Thoracic Radiotherapy: From Discovery to Implementation
- Open Access
- 13 March 2024
- Published by BMJ in BMJ Oncology
- Vol. 3 (1) , e000226
Feasibility of implementing a rapid-learning methodology to inform radiotherapy treatments: key professional stakeholders’ views
Objective Pragmatic methodologies, often termed rapid-learning, are being pursued that can match the pace of innovation in radiotherapy and generate evidence from the real-world treatment setting. It is important to understand the feasibility of implementing such pragmatic approaches before their application in practice. This study investigated key professional stakeholders’ perceptions and opinions of rapid-learning and real-world data (RWD). Methods and analysis Twenty-three interviews were conducted with key professional stakeholders based across five UK radiotherapy cancer centres. Centres varied in size and reflected different healthcare environments. Data were collected between December 2022 and May 2023, and analysed using inductive thematic analysis. Results Four themes were generated: (1) the alignment of rapid-learning methodologies with the reality of practice, (2) concerns related to the variability of RWD, (3) the maturity of data infrastructures and capacity for rapid-learning and (4) further support, education and evidence needed to convince stakeholders to adopt rapid-learning approaches. Conclusion The potential of rapid-learning to help address evidence gaps in radiotherapy development was positively received by different professional stakeholders. However, the effectiveness of rapid-learning was viewed as being highly dependent on the collection of quality data in the routine setting, while the variable set-up at different cancer centres is also likely to be a key challenge for potential implementation. Developing data infrastructures to improve data interoperability was considered crucial for rapid-learning implementation, along with method clarity, educational support and training for radiotherapy teams.
- 13 March 2024
- Published by BMJ in BMJ Oncology
- Vol. 3 (1) , e000226
Open AccessFeasibility of implementing a rapid-learning methodology to inform radiotherapy treatments: key professional stakeholders’ views
Objective Pragmatic methodologies, often termed rapid-learning, are being pursued that can match the pace of innovation in radiotherapy and generate evidence from the real-world treatment setting. It is important to understand the feasibility of implementing such pragmatic approaches before their application in practice. This study investigated key professional stakeholders’ perceptions and opinions of rapid-learning and real-world data (RWD). Methods and analysis Twenty-three interviews were conducted with key professional stakeholders based across five UK radiotherapy cancer centres. Centres varied in size and reflected different healthcare environments. Data were collected between December 2022 and May 2023, and analysed using inductive thematic analysis. Results Four themes were generated: (1) the alignment of rapid-learning methodologies with the reality of practice, (2) concerns related to the variability of RWD, (3) the maturity of data infrastructures and capacity for rapid-learning and (4) further support, education and evidence needed to convince stakeholders to adopt rapid-learning approaches. Conclusion The potential of rapid-learning to help address evidence gaps in radiotherapy development was positively received by different professional stakeholders. However, the effectiveness of rapid-learning was viewed as being highly dependent on the collection of quality data in the routine setting, while the variable set-up at different cancer centres is also likely to be a key challenge for potential implementation. Developing data infrastructures to improve data interoperability was considered crucial for rapid-learning implementation, along with method clarity, educational support and training for radiotherapy teams.